India Pharmaceutical - Search News

News

India, Trump and pharma

Indian pharma stocks decline after Trump again threatens tariffs

(Reuters) -Indian pharmaceutical stocks fell 1.7% on Wednesday after U.S. President Donald Trump reiterated plans to announce a "major" tariff on all pharmaceutical imports. U.S. accounts for a third of India's overall pharma exports.

The New York Times · 2d

India’s Drug Makers Shudder as Trump Again Threatens Tariffs

The United States is India’s biggest market for pharmaceutical exports, which are its most successful industrial exports.

Firstpost · 2d

Trump to tariff pharmaceuticals next. Will this hurt India, a big medicine exporter?

Yet another round of tariffs is expected as Donald Trump reminded the world about his plans to impose heavy tariffs on pharmaceutical imports. India is watching closely, as the US is the largest market for its drug manufacturers.

IndiaWest1d

Meds To Cost More? Trump Now Sets Sights On Pharma, Mostly Supplied By India

WASHINGTON, DC – After sparing pharmaceuticals in his earlier trade battles, President Donald Trump is now toying with the ...

India Brand Equity Foundation14h

Booster shot as India's pharma market grew 8.4% in FY25: Pharmarack

India’s pharmaceutical market grew 8.4% in FY25, led by strong value growth in cardiac, gastrointestinal, and anti-diabetic therapies, according to Pharmarack.

FMCG stocks hold ground in market mayhem, pharma bleeds amid tariff jitters

Meanwhile, the Nifty Pharma index saw all 20 of its constituents trading in the red. Stocks such as Biocon, IPCA Laboratories ...

Trump's Reciprocal Tariffs On India Exempt Pharma, Easing Mark Cuban's Price Hike Concerns

Billionaire entrepreneur and Cost Plus Drugs co-founder Mark Cuban won't have to raise medicine prices, as Trump’s new ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results